BB Biotech AG (BION.S)

BION.S on Swiss Exchange

295.75CHF
6:37am EST
Change (% chg)

CHF5.75 (+1.98%)
Prev Close
CHF290.00
Open
CHF291.50
Day's High
CHF296.00
Day's Low
CHF291.50
Volume
17,685
Avg. Vol
51,375
52-wk High
CHF296.00
52-wk Low
CHF132.10

BION.S

Chart for BION.S

About

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s... (more)

Overall

Beta: 0.93
Market Cap(Mil.): CHF3,359.48
Shares Outstanding(Mil.): 11.85
Dividend: 11.60
Yield (%): 4.09

Financials

  BION.S Industry Sector
P/E (TTM): 2.18 175.69 40.21
EPS (TTM): 129.99 -- --
ROI: 52.40 -2.61 16.34
ROE: 52.40 -4.39 17.27
Search Stocks

BRIEF-BB Biotech net profit for 2014 up to CHF 1.47 bln

* Net profit for 2014 amounts to 1.47 billion Swiss francs ($1.55 billion) versus 931.8 million Swiss francs year ago

20 Feb 2015

BRIEF-BB Biotech increases cash distribution to 11.60 sfr/shr

* Increases tax-efficient cash distribution significantly to chf 11.60 per share Source text for Eikon: Further company coverage:

23 Jan 2015

Activist investor Elliott takes stake in Swiss firm BB Biotech

ZURICH, Nov 17 - Activist investor Elliott Management Corp has become the second largest shareholder in Switzerland's BB Biotech, an investment firm with holdings in about 30 biotech companies.

17 Nov 2014

BRIEF-BB Biotech NAV up 21.2 pct in Q3

* Says net asset value rose 21.2 percent in swiss francs in Q3

16 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks